Skip to main content
Premium Trial:

Request an Annual Quote

Iconix Links DrugMatrix Database with MDL Information Systems Tools

NEW YORK, Jan. 14-Iconix Pharmaceuticals will link its DrugMatrix chemogenomics system with MDL Information Systems' open-platform database management tools, the two companies said today.


Chemists that subscribe to both systems will be able to use MDL ISIS search tools, which allow searches by chemical structure or structure similarity, to probe the genomic, toxicogenomic, and chemical information in the Iconix database.


The partnership offers chemists new ways to access genomic data in their drug discovery and testing work, said Iconix CEO Jim Neal in a statement.


Iconix Pharmaceuticals is a privately owned chemogenomics company based in Mountain View, Calif. MDS Pharma Services and Incyte are involvedin developing and commercializing DrugMatrix, and are both equity investors in the company.


MDL Information Systems is a subsidiary of Elsevier. It is based in San Leandro, Calif.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.